Journal article
E. Gómez-Bañuelos, M. J. Wahadat, Jessica Li, M. Paz, B. Antiochos, A. Celia, Victoria Andrade, Dylan P. Ferris, D. Goldman, E. Darrah, M. Petri, F. Andrade
JCI Insight, 2022
JCI Insight, 2022
Semantic Scholar
DOI
PubMedCentral
PubMed
Cite
Cite
APA
Click to copy
Gómez-Bañuelos, E., Wahadat, M. J., Li, J., Paz, M., Antiochos, B., Celia, A., … Andrade, F. (2022). Alternative exon usage in TRIM21 determines the antigenicity of Ro52/TRIM21 in systemic lupus erythematosus. JCI Insight.
Chicago/Turabian
Click to copy
Gómez-Bañuelos, E., M. J. Wahadat, Jessica Li, M. Paz, B. Antiochos, A. Celia, Victoria Andrade, et al. “Alternative Exon Usage in TRIM21 Determines the Antigenicity of Ro52/TRIM21 in Systemic Lupus Erythematosus.” JCI Insight (2022).
MLA
Click to copy
Gómez-Bañuelos, E., et al. “Alternative Exon Usage in TRIM21 Determines the Antigenicity of Ro52/TRIM21 in Systemic Lupus Erythematosus.” JCI Insight, 2022.
BibTeX Click to copy
@article{e2022a,
title = {Alternative exon usage in TRIM21 determines the antigenicity of Ro52/TRIM21 in systemic lupus erythematosus},
year = {2022},
journal = {JCI Insight},
author = {Gómez-Bañuelos, E. and Wahadat, M. J. and Li, Jessica and Paz, M. and Antiochos, B. and Celia, A. and Andrade, Victoria and Ferris, Dylan P. and Goldman, D. and Darrah, E. and Petri, M. and Andrade, F.}
}
Abstract
The origin and mechanisms of autoantigen generation in systemic lupus erythematosus (SLE) are poorly understood. Here, we identified SLE neutrophils activated in vivo by IFN as a prominent source of Ro52, also known as tripartite motif–containing protein 21 (TRIM21), a critical autoantigen historically thought to be primarily generated by keratinocytes in SLE. Different from mononuclear cells and keratinocytes, SLE neutrophils are enriched in several unique Ro52 species containing a core sequence encoded by exon 4 (Ro52Ex4) in TRIM21. Ro52Ex4 is the main target of anti-Ro52 antibodies and is found in 2 Ro52 variants (Ro52α and an isoform termed Ro52γ) upregulated in SLE neutrophils. Further analysis of Ro52γ revealed a subset of autoantibodies against a unique C-terminal domain (Ro52γCT) generated from a frameshift due to the lack of exon 6 in Ro52γ. Antibodies to Ro52Ex4 and Ro52γCT distinguish SLE patient subsets characterized by distinct clinical, laboratory, treatment, and transcriptional profiles that are not discerned by the “classical” anti-Ro52 antibodies. These studies uncover IFN-activated neutrophils as a key source of unique immunogenic forms of Ro52 in SLE. Moreover, the finding of Ro52Ex4 and Ro52γCT as core targets of anti-Ro52 antibodies focus interest on Ro52γ as the potential isoform toward which immunological tolerance is initially lost in SLE.
